Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.

Kiersten J KugelerLaura J PodewilsNisha B AldenTori L BurketBreanna KawasakiBrad J BiggerstaffHolly M BiggsRachael ZacksMonique A FosterTravis LimEmily McDonaldJacqueline E TateRachel K HerlihyJan DrobeniucMargaret M Cortese

Published in: Public health reports (Washington, D.C. : 1974) (2021)

Testing residual clinical specimens provided a similar seroprevalence estimate yet yielded limited insight into the local epidemiology of COVID-19 and might be less representative of the source population than a cluster-sampled community survey. Awareness of the limitations of various sampling strategies is necessary when interpreting findings from seroprevalence assessments.

Keyphrases

sars cov
cross sectional
mental health
healthcare
coronavirus disease
respiratory syndrome coronavirus
risk factors